The Infection
Clinics Miss

What is Ureaplasma Urealyticum?

Ureaplasma urealyticum belongs to the mycoplasma family — a group of bacteria so small they were invisible to science for decades. What makes them unusual is their complete lack of a cell wall, which is what makes standard antibiotics like amoxicillin useless against them.

It colonises the urogenital tract — the urethra in men, the cervix and vagina in women — and in many people it sits there quietly, causing nothing. But when conditions shift (a new partner, immune suppression, a hormonal change, or simply a high bacterial load), it tips into pathogenic territory. At that point, it stops being a commensal and starts being a problem.

Figure 1: Ureaplasma urealyticum is detected using PCR — the same technology used for COVID-19 testing — because standard culture methods are unreliable.

There are two species: Ureaplasma urealyticum and Ureaplasma parvum. Urealyticum is the more pathogenic of the two and the one most consistently linked to clinical symptoms. Both are sexually transmitted, though the exact threshold at which colonisation becomes infection is still an active area of research.

Symptoms: What Ureaplasma Feels Like

The challenge with Ureaplasma is that its symptoms overlap almost perfectly with other STIs — chlamydia in particular — and it's common to receive treatment for one while the underlying Ureaplasma infection continues untreated.

One of the most important — and under-discussed — consequences of untreated Ureaplasma is its link to fertility. In men, studies have shown that high Ureaplasma burden correlates with sperm DNA fragmentation and reduced motility. In women, chronic upper genital tract infection has been associated with tubal scarring. Both pathways can contribute to difficulty conceiving.

Figure 2: Many patients visit multiple clinics for recurring symptoms before Ureaplasma is considered — because most standard panels simply don't include it.

Why Standard Bangkok STI Panels Miss It

Walk into almost any private clinic or hospital in Bangkok and request an "STI panel." You'll typically receive a combination of HIV (4th gen), syphilis (VDRL/RPR), gonorrhoea (culture or PCR), and chlamydia. These four cover the most prevalent and legally reportable infections — which is why they dominate the standard offering.

Ureaplasma doesn't make that list for several reasons:

The result is a blind spot. Patients who have been treated for "NGU" or "chlamydia" may actually have Ureaplasma — and if the treatment course didn't specifically target it, the infection persists. You feel better briefly, then it returns. This cycle repeats until someone orders the right test.

How to Get Tested for Ureaplasma in Bangkok

Because Ureaplasma lacks a cell wall, it can't be visualised under a standard microscope or grown on routine culture plates. The only reliable detection method is a polymerase chain reaction (PCR) — the same technology used to detect COVID-19.

Figure 3: Sample collection uses a simple urogenital swab or first-catch urine. The process takes under 2 minutes and is entirely non-invasive.

CheckThatMate's Complete 16 PCR panel includes Ureaplasma urealyticum alongside 15 other pathogens in a single panel, using specimens collected by our concierge team at your home, hotel, or office anywhere in Bangkok.

Treatment: What Works (and What Doesn't)

If your result comes back positive, the good news is that Ureaplasma urealyticum is treatable. The bad news is that the wrong antibiotic will do nothing — because without a cell wall, beta-lactam antibiotics (penicillins, cephalosporins, amoxicillin) have no target to attack.

A positive PCR result should always be followed by a consultation with a clinician who can confirm the appropriate antibiotic course for your specific case. Partner notification and simultaneous treatment is strongly recommended to prevent re-infection.

Frequently Asked Questions